Gedeon Richter has launched a dydrogesterone-only hormone replacement therapy (HRT) formulation in the UK, Nalvee, as an option for non-hysterectomised women receiving oestrogen therapy. Nalvee marks ...
Biogen's treatment for neurodegenerative disorder spinal muscular atrophy (SMA) Spinraza has come under pressure in an increasingly competitive market, but the company hopes a new high-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback